"10.1371_journal.pone.0069394","plos one","2013-08-16T00:00:00Z","Annie Albin Lumen; Libin Li; Jiben Li; Zeba Ahmed; Zhou Meng; Albert Owen; Harma Ellens; Ismael J Hidalgo; Joe Bentz","Department of Biology, Drexel University, Philadelphia, Pennsylvania, United States of America; Preclinical Drug Metabolism and Pharmacokinetics, GlaxoSmithKline, King of Prussia, Pennsylvania, United States of America; Absorption Systems LLC, Exton, Pennsylvania, United States of America","Â¶ AAL and LL are joint first authors on this work.","The authors have declared the following interests: Reagents were provided by GSK and by Absorption Systems, who also supported the execution of the experiments. AAL, ZA, ZM and HE are employed by GlaxoSmithKline and LL, JL, AO, and IJH by Absorption Systems LLC. Amprenavir and GF120918 were from GlaxoSmithKline. There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2013","08","Annie Albin Lumen","AAL",9,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
